OUR EFFORTS

OUR EFFORTS

1. Reducing the burden of children having to stick needles in every day

--Research and development of non-invasive blood glucose sensors--

The world’s first non-invasive blood glucose measurement sensor under research utilizes our proprietary technology to eliminate the need for invasive blood glucose measurement.

Quantum Operation supports the activities of Japan IDDM network.

the latest news

Latest News

February 5, 2021

We exhibited at CES2021 and received responses from all over the world.

Quantum Operation Inc. exhibited at CES2021, the world’s largest technology trade show, from January 11 to 13, 2021. At CES2021, the first time All Digital was held, we exhibited a prototype of the world’s first non-invasive continuous blood glucose sensor. We have received a far greater response than we expected, including patients and their families from all over the world who are suffering from daily needles, as well as business companies and investors. We have also been featured in various media around the world. We have received a large number of submissions, so it is not possible to cover all of them, but the main ones are as follows. Nikkei Inc. FT (FINANCIAL TIMES) Engadget.com: Awarded Best of CES finalist Android Authority: Awarded Best wearable innovation PHANDROID: Awarded Best of CES 2021 awards GIZMODO MakeUseOf.com Following CES2021, we have reaffirmed that non-invasive blood glucose sensors are a technology that is attracting global attention, and we all feel a sense of mission to provide these sensors as soon as possible. Kazuma Kato CEO Quantum Operation Inc.

January 11, 2021

Wearable 24/7 glucose monitor (nonstop, needleless) at CES 2021

Quantum Operation’s CES Exhibit to Showcase the World’s First Glucose Measuring Wristband that Enables Truly Nonstop Monitoring Health tech startup will also present a nonstop oxygen saturation (SpO2) monitoring wristband. TOKYO (Jan. 10, 2021) At CES 2021 (Jan. 11-14, online), Quantum Operation Inc., a Tokyo-based healthcare IoT startup, will present the world’s first noninvasive glucose monitor that is capable of truly continuous measurement. The company’s patented spectrum sensing technology enables the monitoring sensor to accurately measure glucose in a person’s bloodstream through the skin while being worn around their wrist. This monitor eliminates the need and pain of daily needle uses for diabetic patients. During CES, Quantum Operation will also showcase its oxygen saturation measuring sensor (SpO2) that can be worn around the wrist. The key to achieving this noninvasive 24/7 monitoring are Quantum Operation’s core technologies that include the novel spectrometer materials one of which is designed to emit an optimal spectrum, and another that is highly responsive to target spectra as well as the innovative firmware that efficiently extract targeted data by canceling noise. These technologies can be …

November 18, 2020

Listed as a participating start-up company in Saitama Sports Start-up (SSS)

Quantum Operation Inc. is listed as a participating start-up company in the 2020 Saitama Sports Start-up (SSS, sponsored by Saitama Prefecture and Saitama Industrial Development Corporation). Participating start-up companies in the 2020 Saitama Sports Start-up (SSS) http://www.pref.saitama. lg.jp/a0803/sogyo-files/sss.html Quantum Operation Inc. is working on the themes presented by Urawa Red Diamonds. We would be happy to report details of our collaboration with them as well as their progress in the future. Translated with www.DeepL.com/Translator (free version)

ABOUT US

ABOUT US

About the Company

Company Name Quantum Operation Inc.
Representative Kazuma Kato
Establishment October 26, 2017
Capital Stock 100,000,000 JPY (As of June 30, 2020)
Location Y’s Building 2F, 1-2-13 Tsukishima, Chuo-ku, Tokyo
Number of employees 22, including executives and contract workers (As of June 30, 2020)
Directors Akira Ikeda, Masanao Takase, Akira Okada,
Sumitaka Maruyama, Kenji Kubo,
Shouzen Ryu, Hideya Nishimura
Auditor Takeshi Yoshida
Advisors Hironami Kubota (Formerly Nihon Kohden),
Kunihide Ichikawa (Formerly Astellas Pharma Inc.),
Kenji Sumi (Formerly Astellas Pharma Inc.),
Dr. Toshiyo Tamura (Next Generation Robotics Laboratory, Waseda University),
Dr. Susumu Kuwaki (Mayus Corporation CEO)
Shareholders Taisho Pharmaceutical Co.,
Alfresa Corporation,
Tomita Pharmaceutical Co. and more
Corresponding Banks Sumitomo Mitsui Banking Corporation,
Nihonbashi Branch and more
Legal Advisors AZX General Law Office; Uchida & Samejima Law Office
Business Alliances and Business Partners Xunlong Software (Shenzhen and Dongguan, China),
Mayus Corporation,
TOHOKU UNIVERSITY,
Chiba University of Science,
Showa University Hospital,
enstem Inc.,
Frog Company Inc.,
Comic M.E. INC.,
Ococias Kyoto AC, and more.

History of the Company

October 2017 Established
October 2017 Business partnership with Xunlong Software (Shenzhen and Dongguan, China)
November 2017 Began the vital data acquisition IoT sensor business.
August 2018 First prototype of the first IoT sensor for acquiring vital data completed.
January 2019 Kunihide Ichikawa was appointed as an advisor.
March 2019 Have commenced third-party allotment of shares through equity crowdfunding.
March 2019 Business partnership with Frog Company, Inc.
July 2019 Business partnership with Tomita Pharmaceutical Co.
November 2019 Business partnership with Taisho Pharmaceutical Co.
January 2020 Business partnership with Alfresa Corporation.
January 2020 Hiro Kubota appointed as an advisor.
February 2020 Start of joint research with Chiba University of Science.
May 2020 Business alliance with Mayus Co.
June 2020 Business partnership with enstem, Inc.
June 2020 Toshiyo Tamura appointed as an advisor.
June 2020 Business partnership with Ococias Kyoto AC.
June 2020 Pre-release of the Heat Stroke Prediction System.
July 2020 Selected to represent Japan at the Global Innovation Forum in Osaka 2020 (GIF).
August 2020 Completed registration of medical device manufacturing business.
September 2020 Obtained medical device certification for Heartbeat, Respiration, and Body Movement Detection Sheet Sensor.
November 2020 Appeared in Nikkei Digital Health: Japanese companies are taking on the challenge of Wearable Medical Devices and creating a new market on the strength of the accuracy of their devices.
November 2020 Listed as a participating start-up company in Saitama Sports Start-up (SSS).
December 2020 Participated in Healthtech/SUM 2020.
December 2020 Participated in a Study Group on Forming Rules for a Harm Reduction Lifestyle.
December 2020 Obtained Type II Medical Device Manufacturing and Sales License.
January 2021 Exhibited at CES2021. Elected as “Best of CES2021 finalist” by Engadget.com
April 2021 Appeared in Forbes Japan.
June 2021 Started joint research about “VINSTA” with AstraZeneca.
June 2021 Exhibited at Arab Health 2021.

How did the representative start the company?

(1) My experience in my hometown, Yubari City, Hokkaido, was the trigger.

In 2007, Yubari City’s finances collapsed.
My father retired from Yubari City Hall under the early retirement program. I started my business in Yubari City in 2016 with a U-turn. That’s where I felt the collapse of healthcare.
The maximum number of beds at the hospital in Yubari was 171, but with the financial collapse, the number of beds was reduced to 19.
It’s a 40-minute drive to the next town, and acute patients will not be able to make it in time.
This was the reality.
Then I thought, why not use the IoT to prevent people from getting sick or becoming seriously ill? I was convinced that making this happen would save the world in the future.

(2) My experience with congenital renal artery stenosis.

When I was in junior high school, my blood pressure was found to be abnormal with my highest blood pressure over 180 and lowest blood pressure over 100.
Initially, the cause was unknown and my arm was tightened every day with cuff blood pressure morning, noon and night.
It was a very painful experience, both physically and mentally, as it affected my life.
In addition to the pain in my arm when the cuff is tightened, I asked myself that was I eating poorly? Is it a genetic abnormality? And it was really painful to see faces of my parents as they apologised to me.
If we could at least make the measurements easier, it would alleviate the physical and mental strain! If blood pressure had been controlled by constant measurement, the range of action would have been increased. This was the event where I felt that constant blood pressure control in people with high blood pressure could save lives.

Profile of the Main Members

Kazuma Kato

Invited as a teacher to join the Transdisciplinary Program for Biomedical Entrepreneurship and Innovation of Osaka University Graduate School of Medicine.
Engaged in the PM of a major mission-critical system at Intec, Inc.
Later, he was co-chair of the Japan School of Policy Making.

He served as CIO of Green Ship, Inc.
He is also a director of the NPO Yubari Tourism Association and a member of the Yubari Chamber of Commerce and Industry.

Junichi Yamagishi

Former technical officer of the Ministry of Transport (present Ministry of Land, Infrastructure and Transport). After submitting his resignation, he worked for his family’s wireless equipment development company to make discrete components practicable for mobile phone digitalization. Engaged in conception, design, manufacturing, and sales at an amusement facility management system company.

Atsushi Komata

Graduated from Shibaura Institute of Technology (Department of Electrical Engineering). He was engaged in the development of home TVs at Sony Corporation for six years, launched the TV business at Uniden Corporation for three years, and then led the Portable Navigation Device business as division manager for two years. After that, he started his own company, Omnibit Corporation.

Shouzen Ryu

Graduated from Tongji University (College of Electronics and Information Engineering). He has worked as a system engineer and experienced success with various system development projects. He is working on solving the world’s problems by developing web, application, sensor and other IT-based systems.

Access

Contact Us

After confirming the input information, click "Confirm input contents".

OptionalCompany Name
RequiredYour Name
OptionalPhone number
RequiredMail Address
RequiredContent of inquiry
RequiredFraud countermeasures
captcha
*Please enter this character string.
Required

Handling of personal information
Please agree to and click the "Confirm input" button to proceed to the confirmation screen.